Wilbe Capital
VC Fund
London, United Kingdom
Wilbe Capital is a VC fund in London focused on Biotechnology and Water. Wilbe is the first full-stack venture firm dedicated to scientists: entrepreneurship + career resources, advocacy, funding and lab space - all in one place. Become a member: www.wilbe.com.
- Total investments:
- 13
- Last investment:
- Lead investor:
- 8%
Last updated:
For AI agents: llms.txt
Industries Wilbe Capital invests in
Stages Wilbe Capital invests in
Countries Wilbe Capital invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Alessandro Philip Maiano
|
|||
Investment Focus
Industry
- Biotechnology 4 (31%)
- Water 1 (8%)
- Energy 1 (8%)
- Nuclear 1 (8%)
- Genetics 1 (8%)
Stage
- Pre-Seed 6 (46%)
- Seed 4 (31%)
- Venture - Series Unknown 2 (15%)
- Series A 1 (8%)
Country
- United Kingdom 6 (46%)
- Germany 2 (15%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Alessandro Philip Maiano
Managing Partner
|
Managing Partner | Total investments: 0 | Find email | |
Jonathan Bean
BSF Fellow
|
BSF Fellow | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
Apoha
|
Stealth stage start-up | $36M / Venture - Series Unknown / Jun 03, 2026 | |
Cyclana Bio
|
Cyclana Bio is to enhancing women's quality of life by offering a fresh approach to therapeutic research. They operate at the human tissue level in the data we collect and the models we build, revolutionising therapeutic discovery. | $6.7M / Pre-Seed / Oct 20, 2025 | |
Proxima Fusion
|
Proxima Fusion is a fusion energy company developing stellarator-based fusion power plants to deliver safe, carbon-free, and commercially viable electricity. The company focuses on commercializing quasi-isodynamic (QI) stellarators, a type of magnetic confinement fusion reactor designed to provide continuous and stable plasma operation. ProximaFusion collaborates closely with research institutions, industrial partners, and energy companies across Europe through the Alpha Alliance, a consortium established to scale the manufacturing and engineering capabilities needed for commercial fusion. The company leverages scientific breakthroughs from the Wendelstein 7-X (W7-X) stellarator while developing proprietary engineering, simulation, and manufacturing technologies to industrialize fusion power generation. | $149.6M / Series A / Jun 11, 2025 | |
Siftr Bio
|
Siftr is a precision therapeutics company that is currently in development. | $1.3M / Pre-Seed / Dec 04, 2024 | |
Watergenics
|
Watergenics mission is to map the water quality of the planet and help the society transit to a renewable economy. | Venture - Series Unknown / Dec 01, 2024 | |
ExpressionEdits
|
ExpressionEdits operates in the biotechnology industry, focusing on the redesign of synthetic DNA instructions. The company utilizes an AI-driven approach to redefine the status quo of protein expression. It is involved in building biology similar to nature. The team at ExpressionEdits includes scientists and engineers who are dedicated todeveloping new technologies. Proteins, a foundational pillar in healthcare and behind every major advancement in biotech and synthetic biology, are at the core of their work. | $13M / Seed / May 29, 2024 | |
Infinitopes
|
Infinitopes is a cancer research organization whose mission is to strengthen the immune system so that it can stop metastases and save lives. The company's platform creates healthcare systems and therapy designs to integrate high-efficiency vector delivery systems with optimal tumor target identification technologies in early-stage clinicaltrials, allowing patients to prevent cancer and tumors from taking their lives | $16M / Seed / Apr 30, 2024 | |
|
Proxima Fusion
|
Proxima Fusion is a fusion energy company developing stellarator-based fusion power plants to deliver safe, carbon-free, and commercially viable electricity. The company focuses on commercializing quasi-isodynamic (QI) stellarators, a type of magnetic confinement fusion reactor designed to provide continuous and stable plasma operation. ProximaFusion collaborates closely with research institutions, industrial partners, and energy companies across Europe through the Alpha Alliance, a consortium established to scale the manufacturing and engineering capabilities needed for commercial fusion. The company leverages scientific breakthroughs from the Wendelstein 7-X (W7-X) stellarator while developing proprietary engineering, simulation, and manufacturing technologies to industrialize fusion power generation. | $21.7M / Seed / Apr 09, 2024 | |
|
Proxima Fusion
|
Proxima Fusion is a fusion energy company developing stellarator-based fusion power plants to deliver safe, carbon-free, and commercially viable electricity. The company focuses on commercializing quasi-isodynamic (QI) stellarators, a type of magnetic confinement fusion reactor designed to provide continuous and stable plasma operation. ProximaFusion collaborates closely with research institutions, industrial partners, and energy companies across Europe through the Alpha Alliance, a consortium established to scale the manufacturing and engineering capabilities needed for commercial fusion. The company leverages scientific breakthroughs from the Wendelstein 7-X (W7-X) stellarator while developing proprietary engineering, simulation, and manufacturing technologies to industrialize fusion power generation. | $7.5M / Pre-Seed / May 30, 2023 | |
|
Watergenics
|
Watergenics mission is to map the water quality of the planet and help the society transit to a renewable economy. | Seed / Jan 01, 2023 | |
| See all 13 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Wilbe Capital invest in?
Wilbe Capital invests primarily in Biotechnology, Water and Energy startups, most often at Pre-Seed and Seed stage. Most of the 13 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Wilbe Capital?
Public channels for Wilbe Capital include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Wilbe Capital?
The team at Wilbe Capital includes Alessandro Philip Maiano (Managing Partner) and Jonathan Bean (BSF Fellow). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
